Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic mice.

Background: Diabetic nephropathy (DN) is the principal cause of end-stage renal disease. Previous studies have shown that clopidogrel can prevent the early progression of renal injury.

Aim: To elucidate whether clopidogrel is beneficial against DN by using a / mouse model.